5589320 FOLLOW‐UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
Dijk, M.J., Rab, M.A.E., Oirschot, B.A., Bos, J.F., Derichs, C., Rijneveld, A.W., Cnossen, M.H., Nur, E., Biemond, B.J., Bartels, M., Jans, J.J.M., Solinge, W.W., Schutgens, R.E.G., Wijk, R., Beers, E.J.
Published in HemaSphere (01.04.2023)
Published in HemaSphere (01.04.2023)
Get full text
Journal Article
3075 Thrombocytopenia (TCP) in adult cancer patients receiving cytotoxic chemotherapy: incidence and relative risk estimates from a retrospective hospital-based cohort study
ten Berg, M.J, Van den Bemt, P.M.L.A, Shantakumar, S, Bennett, D, Voest, E.E, Huisman, A, Van Solinge, W.W, Egberts, T.C.G
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis
van Hout, G.P.J., Jansen of Lorkeers, S.J., Wever, K.E., Sena, E.S., van Solinge, W.W., Doevendans, P.A., Pasterkamp, G., Chamuleau, S.A.J., Hoefer, I.E.
Published in Evidence-based preclinical medicine (01.12.2014)
Published in Evidence-based preclinical medicine (01.12.2014)
Get full text
Journal Article
Pyruvate kinase deficient hemolytic anemia in the Northern Irish population
Percy, M.J., van Wijk, R., Haggan, S., Savage, G.A., Boyd, K., Dempsey, S., Hamilton, J., Kettle, P., Kyle, A., Shepherd, C.W., van Solinge, W.W., Lappin, T.R.J., McMullin, M.F.
Published in Blood cells, molecules, & diseases (01.09.2007)
Published in Blood cells, molecules, & diseases (01.09.2007)
Get full text
Journal Article